Radiotherapy in the management of lung oligometastases

被引:0
|
作者
Bourbonne, V. [1 ,2 ]
Levy, A. [3 ,4 ]
Khalifa, J. [5 ]
Antoni, D. [6 ]
Blais, E. [7 ]
Darreon, J. [8 ]
Le Pechoux, C. [3 ,4 ]
Lerouge, D. [9 ]
Giraud, P. [10 ,11 ]
Marguerit, A. [12 ]
Pourel, N. [13 ]
Riet, F. -g. [14 ]
Thureau, S. [15 ,16 ]
机构
[1] CHU Brest, Radiat Oncol Dept, Brest, France
[2] Univ Bretagne Occidentale, LaTim, Inserm, UMR 1101, Brest, France
[3] Ctr Int Canc Thorac CICT, Dept Radiat Oncol, Gustave Roussy, F-94805 Villejuif, France
[4] Univ Paris Saclay, Fac Med, F-94270 Le Kremlin Bicetre, France
[5] Inst Claudius Regaud, Inst Univ Canc Toulouse Oncopole, Dept Radiat Oncol, Toulouse, France
[6] Inst Cancerol Strasbourg Europe, Inst Claudius Regaud, Toulouse, France
[7] Inst Cancerol Strasbourg Europe, Dept Radiat Oncol, Strasbourg, France
[8] Polyclin Marzet, Dept Radiat Oncol, Pau, France
[9] Ctr Francois Baclesse, Dept Radiat Oncol, Caen, France
[10] Hop Europeen Georges Pompidou, Ctr Francois Baclesse, Paris, France
[11] Univ Paris Cite, Paris, France
[12] Inst Cancerol Montpellier, Paris, France
[13] Inst St Catherine, Dept Radiat Oncol, Avignon, France
[14] Ctr Hosp Pr St Gregoire, Dept Radiat Oncol, F-35760 St Gregoire, France
[15] Ctr Henri Becquerel, Radiotherapy Dept, Rouen, France
[16] Univ Rouen, QuantIF Litis EA4108, Rouen, France
来源
CANCER RADIOTHERAPIE | 2024年 / 28卷 / 01期
关键词
Oligometastasis; Lung; Surgery; Stereotactic radiotherapy; STEREOTACTIC-BODY-RADIOTHERAPY; ABLATIVE RADIATION-THERAPY; LOCATED EARLY-STAGE; QUALITY-OF-LIFE; PHASE-II; COLORECTAL-CANCER; PULMONARY OLIGOMETASTASES; MULTICENTER PHASE-2; PROGNOSTIC-FACTORS; DOSE-ESCALATION;
D O I
10.1016/j.canrad.2023.06.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent years, the development of both medical imaging and new systemic agents (targeted therapy and immunotherapy) have revolutionized the field of oncology, leading to a new entity: oligometastatic disease. Adding local treatment of oligometastases to systemic treatment could lead to prolonged survival with no significant impact on quality of life. Given the high prevalence of lung oligometastases and the new systemic agents coming with increased pulmonary toxicity, this article provides a comprehensive review of the current state-of-art for radiotherapy of lung oligometastases. After reviewing pretreatment workup, the authors define several radiotherapy regimen based on the localization and size of the oligometastases. A comment on the synergistic combination of medical treatment and radiotherapy is also made, projecting on future steps in this specific clinical setting. (c) 2023 Socie ' te ' franc, aise de radiothe ' rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:36 / 48
页数:13
相关论文
共 50 条
  • [1] Stereotactic radiotherapy for lung oligometastases
    Falcinelli, Lorenzo
    Menichelli, Claudia
    Casamassima, Franco
    Aristei, Cynthia
    Borghesi, Simona
    Ingrosso, Gianluca
    Draghini, Lorena
    Tagliagambe, Angiolo
    Badellino, Serena
    Bastia, Michela Buglione di Monale e
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (01) : 23 - 31
  • [2] Role of radiotherapy in the management of brain oligometastases
    Antoni, D.
    Mesny, E.
    El Kabbaj, O.
    Josset, S.
    Noel, G.
    Biau, J.
    Feuvret, L.
    Latorzeff, I.
    CANCER RADIOTHERAPIE, 2024, 28 (01): : 103 - 110
  • [3] Management of pulmonary oligometastases by stereotactic body radiotherapy
    Gamsiz, Hakan
    Beyzadeoglu, Murat
    Sager, Omer
    Dincoglan, Ferrat
    Demiral, Selcuk
    Uysal, Bora
    Surenkok, Serdar
    Oysul, Kaan
    Dirican, Bahar
    TUMORI, 2014, 100 (02) : 179 - 183
  • [4] Stereotactic radiotherapy for liver oligometastases
    Menichelli, Claudia
    Casamassima, Franco
    Aristei, Cynthia
    Ingrosso, Gianluca
    Borghesi, Simona
    Arcidiacono, Fabio
    Lancellotta, Valentina
    Franzese, Ciro
    Arcangeli, Stefano
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (01) : 32 - 39
  • [5] Stereotactic body radiotherapy for oligometastases
    Tree, Alison C.
    Khoo, Vincent S.
    Eeles, Rosalind A.
    Ahmed, Merina
    Dearnaley, David P.
    Hawkins, Maria A.
    Huddart, Robert A.
    Nutting, Christopher M.
    Ostler, Peter J.
    van As, Nicholas J.
    LANCET ONCOLOGY, 2013, 14 (01) : E28 - E37
  • [6] Stereotactic radiotherapy for adrenal oligometastases
    Borghesi, Simona
    Casamassima, Franco
    Aristei, Cynthia
    Grandinetti, Antonella
    Di Franco, Rossella
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (01) : 52 - 56
  • [7] Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria
    Alongi, Filippo
    Mazzola, Rosario
    Figlia, Vanessa
    Guckenberger, Matthias
    TUMORI JOURNAL, 2018, 104 (03): : 148 - 156
  • [8] Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations
    Pezzulla, D.
    Chiloiro, G.
    Lima, E. M.
    Macchia, G.
    Romano, C.
    Reina, S.
    Panza, G.
    Cilla, S.
    Morganti, A. G.
    Cellini, F.
    Gambacorta, M. A.
    Deodato, F.
    CLINICAL & EXPERIMENTAL METASTASIS, 2024, 41 (05) : 667 - 678
  • [9] Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
    Kalinauskaite, Goda G.
    Tinhofer, Ingeborg I.
    Kufeld, Markus M.
    Kluge, Anne A.
    Gruen, Arne A.
    Budach, Volker V.
    Senger, Carolin C.
    Stromberger, Carmen C.
    BMC CANCER, 2020, 20 (01)
  • [10] Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs
    Liu, Xin
    Wu, Lei
    Guo, Tian
    Huang, Zhifeng
    Chen, Sen
    Li, Chenyang
    Liu, Qiufang
    Wang, Fenggang
    PRECISION RADIATION ONCOLOGY, 2024, 8 (02): : 85 - 91